Veni, Vini, ...Verti. Is open innovation a land where IP practitioners fear to tread?

TY - CONF

T1 - Veni, Vini, ...Verti. Is open innovation a land where IP practitioners fear to tread?

AU - Harrison, Peter Stuart

AU - Roberts, Deborah

PY - 2019/12/12

Y1 - 2019/12/12

N2 - Intellectual property (“IP”) management is commonly seen as being driven by concepts of monopoly, exclusivity and secrecy. This presentation will examine the ways in which the intellectual mind-set, and behavioural preferences, of IP practitioners may influence the management and exploitation of IP, and the impact of these thought-patterns and behaviours on their approach to open innovation governance. We suggest that concepts of “property”/”ownership”, combined with inherent risk aversion and a desire for certainty amongst IP practitioners may negatively impact upon their perception of open innovation governance models. In addition this presentation will present preliminary findings of an in-company, qualitative survey of in-house IP practitioners, marketing, and innovation teams examining the degree to which such perceptions impact on their view of open innovation models. Practitioners will be approached from within the pharmaceutical and biotechnology sector. This is a sector which continues to promise solutions to some of the major problems facing humanity today, including countering the growth of anti-biotic resistant diseases through the development of new antimicrobial agents and the use of genetically engineered organisms to deal with food shortages and misdistribution, and environmental degradation.

AB - Intellectual property (“IP”) management is commonly seen as being driven by concepts of monopoly, exclusivity and secrecy. This presentation will examine the ways in which the intellectual mind-set, and behavioural preferences, of IP practitioners may influence the management and exploitation of IP, and the impact of these thought-patterns and behaviours on their approach to open innovation governance. We suggest that concepts of “property”/”ownership”, combined with inherent risk aversion and a desire for certainty amongst IP practitioners may negatively impact upon their perception of open innovation governance models. In addition this presentation will present preliminary findings of an in-company, qualitative survey of in-house IP practitioners, marketing, and innovation teams examining the degree to which such perceptions impact on their view of open innovation models. Practitioners will be approached from within the pharmaceutical and biotechnology sector. This is a sector which continues to promise solutions to some of the major problems facing humanity today, including countering the growth of anti-biotic resistant diseases through the development of new antimicrobial agents and the use of genetically engineered organisms to deal with food shortages and misdistribution, and environmental degradation.

M3 - Paper

T2 - World Open Innovation Conference

Y2 - 12 December 2019 through 13 December 2019

ER -